Kala Bio (KALA) EBITDA Margin (QoQ) (2019 - 2022)
Kala Bio (KALA) EBITDA Margin (QoQ) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Kala Bio | 9.96 Mn | 9.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -223,205.00 |
| Jun 30, 2022 | 101,645.00 |
| Mar 31, 2022 | 26,915.00 |
| Dec 31, 2021 | -167,231.00 |
| Sep 30, 2021 | 10,193.00 |
| Jun 30, 2021 | -8,505.00 |
| Mar 31, 2021 | 42,815.00 |
| Dec 31, 2020 | -13,103.00 |
| Sep 30, 2020 | 139,057.00 |
| Jun 30, 2020 | -67,554.00 |
| Mar 31, 2020 | -16,747.00 |
| Dec 31, 2019 | -22,526.00 |
| Sep 30, 2019 | -39,690.00 |
| Jun 30, 2019 | 64,576.00 |